Elion Energy Co Ltd

Elion Energy Co Ltd

Health CarePharmaceuticals & Biotechnology
  • Price (CNY)7.83
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change26.70%
  • Beta1.0081
Data delayed at least 15 minutes.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

As of Jul 21, 2017, the consensus forecast amongst 2 polled investment analysts covering Elion Energy Co Ltd advises investors to purchase equity in the company. This has been the consensus forecast since the sentiment of investment analysts improved on Jul 21, 2017. The previous consensus forecast advised that Elion Energy Co Ltd would outperform the market.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.

Share price forecast

The one analyst offering a 12 month price target expects Elion Energy Co Ltd share price to rise to 8.50 in the next year from the last price of 7.83.


Historical dividend information is not available for Elion Energy Co Ltd.
Div growth (TTM)8.11%
More ▼

Earnings history & estimates

Elion Energy Co Ltd reported annual 2016 earnings of 0.12 per share on Apr 17, 2017.
Average growth rate+25.00%
More ▼

Revenue history & estimates

Inner Mongolia Elion Clean Energy Company Limited had revenues for the full year 2016 of 11.05bn. This was 37.13% above the prior year's results.
Average growth rate+2.10%
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.